Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Search by expertise, name or affiliation
Protocol No.: V503-003-00-0255: "A Phase III Clinical Trial to Study the Tolerability and Immunogenicity of V503, a Multivalent Human Papillornavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine, in 16- to 26-Year Old Men and 16- to 26-Year Old Women"
Rupp, Richard
(PI)
Pediatrics
Project
:
Research project
Overview
Project Details
Status
Finished
Effective start/end date
1/3/13
→
1/2/15
Funding
Merck Sharp and Cohme Corporation ( Award # ):
$60,640.00
View all
View less